Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

25

Revenue 2014

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Pfizer could raise ‘up to $15bn’ from consumer unit sale

Pfizer could raise ‘up to $15bn’ from consumer unit sale

Pfizer is also not alone in its tinkering, and consumer health assets have been changing hands with some frequency in recent years, with Merck KGaA saying last month it is also ... 2015 asset-swap deal, and Bayer bought Merck &Co's consumer unit for

Merck earmarks €35m for Italian biologics site development

Merck earmarks €35m for Italian biologics site development Merck earmarks 35m for Italian biologics site development. Pharma firm plans new biotech production line at its Bari facility. ... Merck KgAa is set to invest 35m to expand its manufacturing site in the town of Modugno, Bari in Italy, to add a new

Finalists 2017

by Merck KGaA. with support from W2O Group. Talking About Diabetes (TAD) 2016. ... Merck Growth Hormone eHealth Programme. by Merck KGaA. with support from W2O Group.

Deal Watch May 2017

This ratio sounds familiar (see Becton Dickinson above). The second deal Fresenius announced this month is the acquisition of the biosimilar business of Merck KGaA, set up in 2012, for $729m ... 852 (800m) (533 upfront). Merck KGaA (DE) biosimilars.

Merck, Pfizer cue up first EU launch for PD-L1 drug Bavencio

Merck, Pfizer cue up first EU launch for PD-L1 drug Bavencio Merck KGaA and Pfizer's PD-L1 inhibitor Bavencio could be on the EU market from next month, after getting EMA approval as a treatment for the rare skin cancer Merkel ... The new product will be launched first in the UK and Germany, according to Merck,

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics